Misra Basant K, Purandare Harshad R, Ved Rahul S, Bagdia Anshul A, Mare Pandurang B
Department of Neurosurgery and Gamma Knife Surgery, P D Hinduja National Hospital and Medical Research Centre, VS Marg, Mahim, Mumbai-400 016, India.
Neurol India. 2009 May-Jun;57(3):257-63. doi: 10.4103/0028-3886.53263.
The changing trends in the management of vestibular schwannoma (VS) in our practice over the last two decades as well as the current status are presented here.
The observations are based on the experience of 559 consecutive cases of VS operated by the first author between 1987 and 2008, 438 of which were operated by microsurgery and 139 by gamma knife radiosurgery (GKR) (18 of which were previously operated by the authors). A detailed analysis of microsurgically managed patients in two different periods (100 consecutive patients each before 1993 and 2008) were compared to see the changing trend and document current results.
In the initial experience (1990s), the emphasis in microsurgery was preserving life, total excision of tumor and preservation of function in that order. In the 21 st century, the emphasis in microsurgery has been all about functional preservation. In 100 consecutive cases of VS (excluding neurofibromatosis-2) that were treated microsurgically between 2005-08, there were four small tumors (<2 cm), 14 medium-sized tumors (2-3 cm) and 82 large tumors (>or=3 cm). The total excision rate was 83%. The facial nerve anatomical preservation rate was 96% and function was Grade III House-Brackmann (HB) or better in 87%. Both the total excision rate and facial function of Grade II HB or better were 100% in cases with tumor size less than three cm. Functional hearing preservation was achieved in ten cases. There was no operative mortality.
Total excision of VS, though aimed at, is no more pursued at the cost of facial function. Moreover, microsurgery, radiosurgery and observation are all valid options in the management of VS and choosing the correct modality helps in achieving optimal outcome.
本文介绍了过去二十年来我们在实践中前庭神经鞘瘤(VS)管理的变化趋势以及当前状况。
这些观察结果基于第一作者在1987年至2008年间连续手术的559例VS病例的经验,其中438例采用显微手术,139例采用伽玛刀放射外科治疗(GKR)(其中18例先前由作者进行过手术)。对两个不同时期(1993年之前和2008年各100例连续患者)接受显微手术治疗的患者进行了详细分析,以观察变化趋势并记录当前结果。
在最初的经验(20世纪90年代)中,显微手术的重点依次是挽救生命、肿瘤全切和功能保留。在21世纪,显微手术的重点完全在于功能保留。在2005 - 2008年间接受显微手术治疗的100例连续VS病例(不包括神经纤维瘤病2型)中,有4例小肿瘤(<2 cm),14例中等大小肿瘤(2 - 3 cm)和82例大肿瘤(≥3 cm)。全切率为83%。面神经解剖保留率为96%,87%的患者功能为House - Brackmann(HB)Ⅲ级或更好。肿瘤大小小于3 cm的病例中,全切率和Ⅱ级HB或更好的面神经功能均为100%。10例患者实现了功能性听力保留。无手术死亡病例。
虽然旨在实现VS的全切,但不再以牺牲面神经功能为代价。此外,显微手术、放射外科治疗和观察都是VS管理中的有效选择,选择正确的治疗方式有助于实现最佳结果。